IWAA 2016 Annual Scientific Meeting

Park City, UT US
August 4, 2016 to August 6, 2016

To provide clinical relevant topics presented by national recognized speakers in their field. 

Target Audience

Allergy/Immunology Physicians, Family Practitioners and Nurses

Learning Objectives

Overall Learning Objectives:

  • Identify common and uncommon clinical presentations of immunological or allergic disease
  • Describe the benefits and limitations of medication classes presently available to treat immunological or allergic disease
  • Assess the evidence base on new and emerging therapies for immunological or allergic disease.
  • Discuss recent advances in the understanding of pathophysiology of immunological or allergic disease.
Additional information

IWAA 2016 Annual Scientific Meeting 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommenda- tions. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off- label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.


Gerald Gleich, M.D.                              Speaker Consulting/Research Grant: GSK

                                                              Other: Board Member: APFED Other:  Founder: ImmViz

                                                            Other:  Royalties:  Mayo Clinic,Teva

Richard Henry, M.D.                             Moderator

                                                             Other:  Principal Investigator Research: AstraZeneca, Biota, Genentech, Merck, Roche, Sanofi

Joshua Jacobs, M.D.                          Speaker Consulting/Advisory Board: Dyax, Shire, Valeant Research Grant: Biocryst, CSL Behring, Dyax, Shire Speaker:  Dyax, Shire

Rohit Katial, M.D.                               Speaker Consulting/Advisory Board: AstraZeneca, MEDA, Teva Speaker:  MEDA, Teva

David Khan, M.D.                               Speaker Speaker/Honorarium: Genentech

                                                           Other: DSMB: Aimmune

Daniel More, M.D.                             Speaker Other:  Contributor: About.com

Carl Thornblade, M.D.                      Moderator

                                                          Research Study-Independent Contractor:  AstraZeneca, Circassia, GSK, Merck, Mylan, Sanofi, Teva

Richard Wasserman, M.D., PhD        Speaker

                                                        Consulting/Advisory Board: ADMA Biologicals, Baxalta, CSL Behring, Grifols, Kedrion, Prometic, Secretory IgA, Therapure

                                                        Honorarium: Baxalta, CSL Behring

                                                       Research Grant: ADMA Biologicals, Baxalta, Bioplasma Labs, CSL Behring, Kedrion, Therapure Speaker: Baxalta, CSL Behring

                                                      Other:  Stocks:  Secretory IgA

Kenneth Yeager PhD                      Speaker Consulting/Advisory Board: Ohio Lawyers Assistance Program Honorarium:  ACAAI, Oxford University Press review

                                                     Speaker: ACAAI


The following have no relevant financial relationships to disclose: Ernest Charlesworth, M.D.  Speaker

Ronald England, M.D.              Moderator

Jim Thompson PhD                 Speaker

Gregory Wickern, M.D.             Moderator

Doug Huneywell                       Planner



Course summary
Available credit: 
  • 15.00 AMA PRA Category 1 Credit™
  • 15.00 Attendance
Course opens: 
Course expires: 
Event starts: 
08/04/2016 - 7:00pm CDT
Event ends: 
08/06/2016 - 4:30pm CDT
Grand Summit Hotel
4000 Canyons Drive
Park City, UT 84098
United States

Available Credit

  • 15.00 AMA PRA Category 1 Credit™
  • 15.00 Attendance
Please login or create an account to take this course.